HRT Financial’s Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant FACA.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,000
Closed -$494K 3609
2022
Q3
$494K Hold
50,000
0.01% 1589
2022
Q2
$491K Hold
50,000
0.01% 1631
2022
Q1
$497K Hold
50,000
﹤0.01% 1765
2021
Q4
$503K Hold
50,000
﹤0.01% 1761
2021
Q3
$480K Sell
50,000
-109
-0.2% -$1.1K ﹤0.01% 2035
2021
Q2
$518K Buy
50,109
+109
+0.2% +$1.13K ﹤0.01% 1734
2021
Q1
$505K Buy
+50,000
New +$526K 0.01% 1769

HRT Financial's FACA.U Position: Q4 2022 in Review

HRT Financial sold out of Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant (FACA.U) in Q4 2022, closing a stake of 50,000 shares — an estimated $494K sold.

HRT Financial first reported a position in FACA.U in Q1 2021 and held it in 7 quarters. The position peaked at $518K in Q2 2021. 0 funds tracked by Wall St. Rank hold FACA.U as of Q4 2022.

  • HRT Financial reported no remaining Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 50,000 Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant shares in Q4 2022, an estimated $494K.
  • HRT Financial first reported a position in Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant in Q1 2021 and held it in 7 quarters.
  • HRT Financial's Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant position peaked at $518K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.